The House Energy and Commerce Subcommittee on Health has reportedly approved draft legislation that would change the existing lot-level prescription-drug-tracking system to a unit-level system. The proposal would require various entities along the pharmaceutical supply chain, including manufacturers and wholesale manufacturers, to submit information. The subcommittee also apparently approved a bill (H.R. 1407) that would renew the user fees that support the Food and Drug Administration’s approval of brand-name and generic drugs for animals.
Meanwhile, the U.S. Senate passed a measure (S. 622) by unanimous consent that would also extend the animal-drug user-fee system, which will otherwise expire on October 1, 2013. See U.S. House Energy & Commerce Committee News Release, May 8, 2013; CQ Weekly, May 13, 2013.